Clavulanic Acid)为阿莫西林与克拉维酸按2∶1制成的复合制剂，供口服。每片含阿莫西林0.25g和克拉维酸钾0.125g；另有注射剂(含阿莫西林钠1.0g，克拉维酸钾0.2g)供静脉给药。本品对肺炎，上呼吸道感染、扁桃体炎、中耳炎、鼻窦炎、软组织感染、泌尿系统感染、伤寒、痢疾及败血症等疗效较好。副作用...
1 g/125 mg deux fois par jour versus 500 mg/125 mg trois fois par jour dans les exacerbations aiguës de bronchite chronique. Étude multicentrique, comparative, randomisée, en double aveugleEfficacy and tolerance of two oral dosages of Augmentin® 1 g/125 mg twice a day versus 500...
AMOXICILLINE/ACIDE CLAVULANIQUE 500 mg/50 mg Enfant et Nourrisson poudre pour solution injectable (IV), 1 g/200 mg Adulte poudre et solvant pour solution injectable (IV), 1 g/200 mg Adulte poudre pour solution injectable (IV), 2 g/200 mg Adulte poudre pour solution injectable (IV) ...
A1756-100g Acetone oxime 丙酮肟 [127-06-0] 100gA4087-25g N-Acetyl-DL-alanine N-乙酰-DL-丙氨酸 [1115-69-1] 25gA4055-25g N-Acetyl-L-alanine N-乙酰-L-丙氨酸 [97-69-8] 25gA2821-500g Acetylaniline 乙酰苯胺 [103-84-4] 500g Augmentin 安美汀-复方抗生素厂商 ...
The authors had for aim to assess and to compare the clinical efficacy and tolerance of co-amoxiclav 1 g/125 mg, twice a day (group 1), versus the reference formulation of co-amoxiclav 500 mg/125 mg thrice a day (group 2) in the treatment of acute exacerbation of chronic obstructive ...
0.625g(C16H19N3O5S 0.5g:C8H9NO5 0.125g) 单位: --- 持证商: Beecham Group 上市国家: 欧盟上市 什么是参比制剂?参比制剂用于仿制药的开发以证明仿制产品与原研产品的质量是否一致,是仿制药开发成败的关键因素。参比制剂如此重要,那么,该如何选择参比制剂呢?为了配合一致性评价工作,国家药品监督管理局会...
This study aimed to assess and to compare the clinical efficacy and tolerance of co-amoxiclav 1 g/125 mg twice daily (group 1), versus the reference formulation of co-amoxiclav 500 mg/125 mg three times/day (group 2) in the treatment of acute exacerbation of chronic obstructive bronchitis....
5. Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D (2006) "Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, ...
Augmentinis a medicine that combines amoxicillin, a β-lactam antibiotic, with clavulanate, a β-lactamase inhibitor. Why is it important that the two compounds have similar pharmacokinetics (e.g., oral bioavailability and plasma half-life) in humans?
Class 4 Drug Alert (Caution in Use): Amoxil Vials for Injection 500mg and 1g, Augmentin Intravenous 600mg and 1.2g manufactured by Beecham Group PLC and Be... Medicines and Healthcare products Regulatory Agency (MHRA), www.mhra.gov.uk, info@mhra.gsi.gov.uk - Medicines and Healthcare ...